ArticleMedical sciences (Basel, Switzerland)2026
De Novo Actionable Genomic Alterations in High-Grade Pulmonary Neuroendocrine Carcinomas: Therapeutic Implications of Targeted Treatment.
Ari Raphael et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.